Supreme Court Opinion Delivers Blow to Drug Patent Holders
August 24, 2016
The Supreme Court of the United States recently ruled in favor of generic drug manufacturers and advocates for lower drug prices in a patent-law case, the result of which, brand name manufacturing stakeholders argue, hinders continued investments in vital drug research and development.